Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only Get Premium

HQY Healthequity Inc

Price (delayed)

$102.4

Market cap

$8.86B

P/E Ratio

73.14

Dividend/share

N/A

EPS

$1.4

Enterprise value

$9.67B

HealthEquity and its subsidiaries administer HSAs and other consumer-directed benefits for its more than 12 million accounts in partnership with employers, benefits advisors, and health and retirement plan providers who ...

Highlights
HQY's net income has surged by 51% year-on-year and by 26% since the previous quarter
HQY's EPS has surged by 51% year-on-year and by 26% since the previous quarter
HQY's quick ratio is up by 31% since the previous quarter but it is down by 11% year-on-year
The debt has increased by 13% year-on-year

Key stats

What are the main financial stats of HQY
Market
Shares outstanding
86.48M
Market cap
$8.86B
Enterprise value
$9.67B
Valuations
Price to earnings (P/E)
73.14
Price to book (P/B)
4.17
Price to sales (P/S)
7.14
EV/EBIT
44.49
EV/EBITDA
25.48
EV/Sales
7.78
Earnings
Revenue
$1.24B
Gross profit
$814.43M
Operating income
$203.78M
Net income
$121.81M
EBIT
$217.45M
EBITDA
$379.7M
Free cash flow
$283.64M
Per share
EPS
$1.4
EPS diluted
$1.37
Free cash flow per share
$3.27
Book value per share
$24.55
Revenue per share
$14.34
TBVPS
$6.79
Balance sheet
Total assets
$3.42B
Total liabilities
$1.29B
Debt
$1.11B
Equity
$2.12B
Working capital
$356.45M
Liquidity
Debt to equity
0.52
Current ratio
4.06
Quick ratio
3.47
Net debt/EBITDA
2.16
Margins
EBITDA margin
30.5%
Gross margin
65.5%
Net margin
9.8%
Operating margin
16.4%
Efficiency
Return on assets
3.5%
Return on equity
5.7%
Return on invested capital
16.9%
Return on capital employed
6.6%
Return on sales
17.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

HQY stock price

How has the Healthequity stock price performed over time
Intraday
1.11%
1 week
-2.35%
1 month
-1.31%
1 year
22.55%
YTD
6.72%
QTD
-2.25%

Financial performance

How have Healthequity's revenue and profit performed over time
Revenue
$1.24B
Gross profit
$814.43M
Operating income
$203.78M
Net income
$121.81M
Gross margin
65.5%
Net margin
9.8%
HQY's net income has surged by 51% year-on-year and by 26% since the previous quarter
HQY's operating income is up by 50% year-on-year and by 26% since the previous quarter
The net margin has increased by 27% year-on-year and by 21% since the previous quarter
Healthequity's operating margin has increased by 25% YoY and by 21% from the previous quarter

Price vs fundamentals

How does HQY's price correlate with its fundamentals

Growth

What is Healthequity's growth rate over time

Valuation

What is Healthequity stock price valuation
P/E
73.14
P/B
4.17
P/S
7.14
EV/EBIT
44.49
EV/EBITDA
25.48
EV/Sales
7.78
HQY's EPS has surged by 51% year-on-year and by 26% since the previous quarter
The P/E is 3.9% lower than the last 4 quarters average of 75.3
The stock's P/B is 29% above its 5-year quarterly average of 3.2 and 11% above its last 4 quarters average of 3.7
HQY's revenue is up by 19% year-on-year and by 3.6% since the previous quarter
The stock's price to sales (P/S) is 5% more than its 5-year quarterly average of 6.7 and 5% more than its last 4 quarters average of 6.7

Efficiency

How efficient is Healthequity business performance
The ROE has grown by 43% YoY and by 24% from the previous quarter
The ROA has grown by 35% YoY and by 25% from the previous quarter
HQY's ROIC is up by 24% YoY and by 20% QoQ
HQY's return on sales is up by 22% year-on-year and by 19% since the previous quarter

Dividends

What is HQY's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for HQY.

Financial health

How did Healthequity financials performed over time
Healthequity's total assets is 164% higher than its total liabilities
Healthequity's current ratio has increased by 33% QoQ but it has decreased by 8% YoY
HQY's quick ratio is up by 31% since the previous quarter but it is down by 11% year-on-year
The debt is 48% smaller than the equity
The debt has increased by 13% year-on-year
The debt to equity has grown by 11% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.